A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group (Q35693076)
Jump to navigation
Jump to search
scientific article published on 4 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group |
scientific article published on 4 August 2011 |
Statements
1 reference
A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group (English)
1 reference
K D Miller
1 reference
A O'Neill
1 reference
E A Perez
1 reference
A D Seidman
1 reference
G W Sledge
1 reference
4 August 2011
1 reference
1 reference
1 reference
Identifiers
1 reference